The independent source for health policy research, polling, and news.
17,021-17,040 of 112,988 results
The company expects results of its phase 3 trial by next week, and once its vaccine is approved, it would be the third vaccine in the U.S. Sanofi, while awaiting development of its vaccine, says it can help manufacture Pfizer's beginning this summer.
The Biden administration wants to purchase enough additional covid vaccine from Moderna and Pfizer to inoculate all American adults by the end of summer. He also announced plans to try to smooth immediate distributions efforts to the states.
Today's early morning highlights from the major news organizations.
Opinion pages look at the public health issues surrounding attempts to reopen public schools and several other health issues, as well.
As new covid variants threaten faster spreading of the virus, editorial pages focus on how long it will take to achieve herd immunity through vaccination.
The data, based on the Pfizer vaccine, is "very encouraging" news, said an official from one of the country's health groups. News reports are also from Australia, New Zealand, Taiwan, parts of the European Union and Canada, as well.
Cleanup crews say it will take a month or longer to return 57 residents to the home in Monett, Missouri. Also, Idaho votes to delay an amendment vote banning marijuana; Consumer Reports looks at challenges for safe pregnancies; and more.
The groups collaborated on a scientific paper detailing what football players learned about covid safety protocol. In other news, Budweiser says it will skip its Super Bowl ad for the first time since 1983 and put the money toward vaccine education.
The rule is meant to give consumers information about prices for medical goods and services. The fine of $300 a day isn't a strong enough incentive for hospitals, an investigation reports.
A UCSF-led team says Aplidin could be more effective than remdesivir. Meanwhile, news stories report on the impact of the virus on animals, more lung cancers being detected among never-smokers and more.
An Axios-Ipsos poll taken Jan. 22-25 found that 58% of respondents overall trust President Joe Biden to give them accurate information, compared to the 27% who said they trust Donald Trump.
The state is sailing through the vaccine rollout with few problems. Other places that are making good progress include Alaska and rural Kittitas County in Washington state.
Other national news is on Pfizer's vaccine vials, how Big Business is trying to help the vaccine distribution effort, why companies are unlikely to require employees to get the shot and more.
The Biden administration has selected nurse Susan Orsega to serve as the nation’s acting surgeon general, The Washington Post reports.
Health care workers, residents 65 and older, teachers, farmworkers and first responders still get priority. But there will be a shift in who gets the vaccine after them. Other state news is from North Carolina, Oklahoma, Nevada, New Mexico, Maryland and New Jersey.
President Joe Biden voiced optimism that the 50% increase is achievable, but that first "we have to meet that goal of one million a day.”
Merck says that neither of its experimental vaccines produced adequate immune responses against the coronavirus in its clinical trial testing. The drugmaker says it will focus its efforts on developing treatments.
The CDC has not recommended it yet and there's no scientific evidence to support it, but the topic went viral when some high-profile people at the inauguration did it.
The drugmaker is developing two potential boosters to its covid vaccine -- one to increase efficacy against the virus variant discovered in South Africa and another that targets future variants.
Positive trends continue in the covid fight with hospitalizations falling below 110,000 for the first time since mid-December and new daily infections averaging around 170,000.
© 2026 KFF